Blood transcriptomic signature in type-2 biomarker-low severe asthma and asthma control 🔗 Access full article via Journal of Allergy and Clinical ImmunologyShare:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
